MAPK3 and prostate cancer: Chen suggested that PRKD3 could promote prostate cell proliferation by activating downstream AKT and ERK1/2 molecules, and the absence of PRKD3 could lead to the arrest of cell cycle G0/G1 phase of prostate cancer cell line (Chen et al., 2008).